The Patent Finder
US

Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy

US 9,377,454 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Horizon Pharma Rheumatology LLC, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Jun 25, 2030 · High confidence

Filed Aug 8, 2012 as application 13/379,704 · Granted Jun 28, 2016
Base term, 20 years from filing
Today
20 years from filing
2010 2030
Clock starts
Jun 25, 2010
Term ends
Jun 25, 2030
Granted
Jun 28, 2016
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
13
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 25, 2010, when application PCT/US2010/040082, the earliest non-provisional in its chain, was filed (this one was filed Aug 8, 2012)Jun 25, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJun 25, 2030High confidence

Partial family

Application PCT/US2010/004008PCT application
no patent term
no patent term
Application PCT/US2010/040082PCT application
no patent term
no patent term
US 9,377,454this patent
Jun 2030
Jun 2030
Application 15/165,318Abandoned
not computed
not computed
US 10,139,399In force
Jun 2030
Jun 2030
US 10,823,727In force
Jun 2030
Jun 2030
US 11,639,927In force
Jun 2030
Jun 2030
US 11,598,767In force
Jun 2030
Jun 2030
8 of 13 applications in this family shown, earliest filings first. Partial: 1 of the 13 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 12, 2012
Reel 28363, frame 40
Savient Pharmaceuticals, Inc.Morgan Stanley Senior Funding Inc.Security Agreement
Aug 3, 2012
Reel 28715, frame 585
Rosario-jansen, Theresa; Wright, David ErickSavient Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jul 23, 2013
Reel 30936, frame 72
Savient Pharmaceuticals, Inc.U.S. National Bank Association, as Collateral AgentCorrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement.
Feb 21, 2014
Reel 32319, frame 77
Crealta Pharmaceuticals LLCJefferies Finance LLC, as Collateral AgentSecurity Agreement
Apr 15, 2014
Reel 32675, frame 936
Savient Pharmaceuticals, Inc.; Savient Pharma Holdings, LLCCrealta Pharmaceuticals LLCAssignment of Assignor's Interest
Jan 13, 2016
Reel 37483, frame 49
Fifth Street Finance Corp., as Collateral AgentCrealta Pharmaceuticals LLCRelease of Security Interest
Jan 13, 2016
Reel 37483, frame 148
Jefferies Finance LLC, as Collateral AgentCrealta Pharmaceuticals LLCRelease of Security Interest
Sep 16, 2016
Reel 40059, frame 7
Horizon Pharma Rheumatology LLC (Formerly Known as Crealta Pharmaceuticals LLC)Citibank, N.A., as Collateral AgentPatent Security Agreement
Nov 18, 2016
Reel 40648, frame 361
Crealta Pharmaceuticals LLCHorizon Pharma USA Rheumatology LLCChange of Name
Nov 18, 2016
Reel 40648, frame 367
Horizon Pharma USA Rheumatology LLCHorizon Pharma Rheumatology LLCChange of Name
Oct 31, 2022
Reel 61805, frame 76
Horizon Pharma Rheumatology LLCHorizon Therapeutics USA, Inc.Assignment of Assignor's Interest
Dec 1, 2022
Reel 62073, frame 930
Horizon Pharma Rheumatology LLCHorizon Therapeutics USA, Inc.Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 061805 Frame 0076. Assignor(S) Hereby Confirms the Assignment.
Jun 16, 2023
Reel 64009, frame 261
Savient Pharmaceuticals, Inc.; Savient Pharma Holdings, Inc.Crealta Pharmaceuticals LLCCorrective Assignment to Correct the Seller's Name and Execution Date Previously Recorded on Reel 032675 Frame 0936. Assignor(S) Hereby Confirms the Seller's Name Should Read Savient Pharma Holdings, Inc. and the Execution Date for Both Parties Should Read 01/09/2014.
Oct 6, 2023
Reel 65178, frame 965
Citibank, N.a.Horizon Therapeutics USA, Inc.Release of Security Interest
Nov 6, 2026
Reel 76662, frame 840
Horizon Therapeutics USA, Inc.Horizon Therapeutics Ireland DacAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited